April 4, 2023
BANGKOK — HOYA Vision Care’s MiYOSMART spectacle lenses for myopia management are taking on a new form: sun spectacle lenses. The latest line, dubbed “MiYOSMART sun range,” will reach 30 countries in the coming months with an official rollout starting this month. (They are not yet available in the United States.)
The photochromic spectacle lenses, MiYOSMART Chameleon, and polarized spectacle lenses, MiYOSMART Sunbird, were developed to slow myopia progression in children using D.I.M.S. Technology while providing protection from intense sunlight.1-5 These two new products, along with the MiYOSMART clear spectacle lenses that launched in 2018, give children the freedom to comfortably take part in the activities they enjoy indoors and outdoors without compromising their eyesight.
MiYOSMART Chameleon and MiYOSMART Sunbird both provide protection from intense sunlight, while simultaneously correcting the myopic refractive error and slowing myopia progression.1-5 The new spectacle lenses utilize the same D.I.M.S. Technology used in the award-winning6,7 and noninvasive MiYOSMART clear spectacle lenses, shown to slow myopia progression by 60% in children aged 8 to 13.3
Due to its HOYA photochromic lens technology, MiYOSMART Chameleon is an all-in-one solution to myopia management and protected outdoor activity. It rapidly adapts to the level of sunlight and fades back to clear indoors in seconds.8 Meanwhile, MiYOSMART Sunbird is the ideal addition to MiYOSMART clear spectacle lenses, for extra protection from intense sunlight and glare.1,9,10 It also offers vibrant colors and rich contrast in bright light, allowing children to fully experience the beauty of the outdoors.11
“Children’s vision is worth protecting. By acting today, we give them more opportunity tomorrow,” said Frederiek Ysebaert, Managing Director of the Pediatric Care Business Unit at HOYA Vision Care. “With the launch of MiYOSMART sun spectacle lenses, inspired by our discussions with eye care professionals, we can enable children across the world to spend more time outdoors while protecting their eyes from intense sunlight, maximizing the benefits of D.I.M.S. Technology on myopia progression.”
Alongside the launch of the MiYOSMART sun range, HOYA Vision Care will launch “Protect How They See the World,” a dedicated global campaign to raise awareness of the importance of outdoor time and sun protection in children. Spending time outdoors may slow down myopia progression in children,6,7 and as such, it is the most common recommended behavioral management for myopia given by eye care professionals.8 However, as the majority of lifetime sun exposure occurs under the age of 21, it is necessary to prevent long-term eye damage to children’s eyes with effective and reliable sun protection.1,9 This is particularly important for myopic children using atropine eye drops for myopia management and those who are light sensitive.2,10,11
From the launch in 2018 until the end of 2022, over four million MiYOSMART spectacle lenses were purchased by parents across the world.18 With the launch of MiYOSMART Chameleon and MiYOSMART Sunbird, HOYA Vision Care will continue to help fight and control the growing problem of myopia around the world.
Product Disclaimer: MiYOSMART spectacle lenses have not been approved for use in the management of myopia in all countries, including the U.S., and are not currently available for sale in all countries, including the U.S
1. WSPOS. Sunlight Exposure & Children’s Eyes Consensus Statement. 2016. Available at: https://www.wspos.org/wspos-sunlight-exposure-childrens-eyes-consensus-statement/ (Last accessed 28/03/2023)
2. Wu PC, Chuang MN, Choi J, et al. Update in myopia and treatment strategy of atropine use in myopia control. Eye (Lond). 2019;33(1):3-13.
3. Lam CSY, Tang WC, Tse DY, et al. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104(3):363-368.
4. Lakkis C, Weidemann K. Evaluation of the performance of photochromic spectacle lenses in children and adolescents aged 10 to 15 years. Clin Exp Optom. 2006;89(4):246-252.
5. Renzi-Hammond LM, Hammond BR Jr. The effects of photochromic lenses on visual performance. Clin Exp Optom. 2016;99(6):568-574.
6. Winners of the exhibition’s grand prix. Inventions Geneva. N.D. Available from: https://inventions-geneva.ch/en/winners/ (Last accessed 28/03/2023)
7. Winners 2020. Silmo Paris. 2020. https://en.silmoparis.com/SILMO-d-OR/SILMO-d-OrAwards/2020-Winners# (Last accessed 28/03/2023).
8. Hoya data on file. HOYA Internal Product Performance Validation. 09/2022
9. Hoya data on file. UVA and UVB transmittance for MiYOSMART photochromic and polarized sun spectacle lenses. 07/2022
10. Hoya data on file. Luminous transmittance for MiYOSMART polarized sun spectacle lenses. 07/2022
11. Quintana MS, Langa A, del Moral-Martinez I, et al. Polarized Filters Enhance Contrast Sensitivity When Glare Is Produced On A Flat Surface Under Photopic Conditions. Invest Ophthalmol Vis Sci. 2006;47(13):1225.
12. Ho CL, Wu WF, Liou YM. Dose-Response Relationship of Outdoor Exposure and Myopia Indicators: A Systematic Review and Meta-Analysis of Various Research Methods. Int J Environ Res Public Health. 2019;16(14):2595.
13. Jonas JB, Ang M, Cho P, et al. IMI prevention of myopia and its progression. Invest Ophthalmol Vis Sci. 2021;62(5):6.
14. WSPOS. Myopia Survey Data. November 2022. Presented as part of WSPOS Symposium: Comprehensive Update on Myopia Management.19-20 November 2022. Available from: http://forum.wspos.org/symposium-part-1-comprehensive-update-on-myopia-management-2
15. Prevent Blindness. Children’s Eyes are More Susceptible to Long-Term Damage from UV Rays. 2011. Available at: Children’s Eyes are More Susceptible to Long-Term Damage from UV Rays (preventblindness.org) (Last accessed 28/03/2023)
16. Li FF, Yam JC. Low-Concentration Atropine Eye Drops for Myopia Progression. Asia Pac J Ophthalmol (Phila). 2019;8(5):360-365.
17. Gong Q, Janowski M, Luo M, et al. Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-analysis. JAMA Ophthalmol. 2017;135(6):624-630.
18. Based on number of MiYOSMART lenses sold as per Hoya sales data on file as of December 2022.